跳至主要内容
临床试验/JPRN-UMIN000020692
JPRN-UMIN000020692已完成未知

The relationship between anti-Xa activity and the renal function in elderly patients who are on apixaban - The relationship between anti-Xa activity and the renal function in elderly patients who are on apixaban

Keio University School of Medicine0 个研究点目标入组 100 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
70years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients contraindicated for apixaban (1)Patients with a history of a hypersensitivity to the ingredients of apixaban (2)Patients with bleeding symptoms which can be of a clinical concern within 6 months (e.g., active gastric ulcers, platelets < 100000, hemoglobin < 10 g/dL, and s stroke within 10 days) (3)Patients with blood clotting defects and liver disease with a clinically important bleeding risk (4)Patients with renal failure (creatinine clearance < 15 mL/min) Severe liver dysfunction (AST and ALT of > 2-fold the upper limits of normal (ULN) and a total bilirubin of > 1.5-fold the ULN) Patients with valvular disorders requiring surgery Patients who cannot orally take drugs or visit the Outpatient Unit on a regular basis Patients with a prognosis of < one year Patients anticoagulated with heparin or enoxaparin

研究者

相似试验